Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity

Journal:

Science Advances

Published:

2026-04-24

DOI:

10.1126/sciadv.aea8737

Affiliations:

8

Authors:

11

Go to article

Institutions	Authors	Share
The University of Texas Health Science Center at San Antonio (UT Health San Antonio), United States of America (USA)	7.000000	0.64
Mayo Clinic Hospital - Phoenix, United States of America (USA)	2.000000	0.18
Kantonsspital St. Gallen, Switzerland	1.000000	0.09
Tsinghua University, China	0.500000	0.05
Changping Laboratory, China	0.500000	0.05

Interested in Oncology and Carcinogenesis?